This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Renotarget Therapeutics, Inc.. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Jujun Wang: Innovator in Cancer Treatment
Introduction
Jujun Wang is a notable inventor based in Plano, TX (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of new therapeutic molecules.
Latest Patents
Jujun Wang holds a patent for a class of quinolone heterocyclic aromatic molecules aimed at cancer treatment. This invention, known as Renotinibs, is particularly focused on treating cancers that harbor abnormal human epidermal growth factor receptors (EGFRs). His work in this area represents a promising advancement in oncology.
Career Highlights
Wang is associated with Renotarget Therapeutics, Inc., where he continues to develop groundbreaking solutions for cancer therapy. His dedication to research and innovation has positioned him as a key figure in the fight against cancer.
Collaborations
Some of his notable coworkers include Allen Tsao and Xiaomei Liu, who contribute to the collaborative efforts in advancing cancer treatment technologies.
Conclusion
Jujun Wang's work exemplifies the impact of innovative thinking in the medical field, particularly in cancer treatment. His contributions through patents and collaboration with other professionals highlight the importance of research in developing effective therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile